Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC I Acquisition Unit | ASCAU | May 31, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | May 31, 2024 | 11.20 | 0.00 |
A-Mark Precious Metals | AMRK | May 31, 2024 | 37.94 | -0.16 |
a.k.a Brands | AKA | May 31, 2024 | 16.95 | +10.28 |
A.O Smith | AOS | May 31, 2024 | 83.64 | +1.93 |
A10 Networks | ATEN | May 31, 2024 | 15.15 | +0.33 |
A2Z Smart Technologies | AZ | May 31, 2024 | 0.43 | +10.12 |
AAA - A Rated Corporate Bond Ishares | QLTA | May 31, 2024 | 46.76 | +0.41 |
Aadi Bioscience | AADI | May 31, 2024 | 1.80 | +3.75 |
AAON | AAON | May 31, 2024 | 75.05 | +0.16 |
AAR | AIR | May 31, 2024 | 70.99 | +1.66 |
Abacus Life | ABL | May 31, 2024 | 11.41 | +13.53 |
Abbott Laboratories | ABT | May 31, 2024 | 102.19 | +0.44 |
AbbVie | ABBV | May 31, 2024 | 161.24 | +3.15 |
AbCellera Biologics | ABCL | May 31, 2024 | 3.92 | -2.97 |
Abeona Therapeutics | ABEO | May 31, 2024 | 4.38 | +4.04 |
Abercrombie & Fitch | ANF | May 31, 2024 | 172.87 | -3.14 |
Aberdeen Asia-Pacificome Fund | FAX | May 31, 2024 | 2.65 | +1.53 |
Aberdeen Australia Equity Fund | IAF | May 31, 2024 | 4.20 | 0.00 |
Aberdeen Emerging Markets Fund | AEF | May 31, 2024 | 5.14 | -1.91 |
Aberdeen Global Fund | FCO | May 31, 2024 | 5.50 | +1.10 |
Aberdeen Global Infrastructure | ASGI | May 31, 2024 | 18.75 | +0.37 |
Aberdeen Income Credit Strategies Fund | ACP | May 31, 2024 | 6.70 | +1.06 |
Aberdeen Income Credit Strategies Pref | ACP-A | May 31, 2024 | 24.88 | +1.03 |
Aberdeen Japan Equity Fund | JEQ | May 31, 2024 | 5.95 | +0.59 |
Abits Group | ABTS | May 31, 2024 | 0.66 | -2.94 |
Abivax SA - American Depositary Shares | ABVX | May 31, 2024 | 14.00 | +4.95 |
Able View Global | ABLV | May 31, 2024 | 1.12 | +1.82 |
ABM Industries | ABM | May 31, 2024 | 47.27 | +1.31 |
Abrdn Global Dynamic Dividend Fund | AGD | May 31, 2024 | 9.54 | +0.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.